Gauss Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$160M
- Investors
-
1
Gauss General Information
Description
Developer of an artificial intelligence-based medical device designed to provide real-time monitoring of surgical blood loss. The company's device leverages computer vision and machine learning to deliver mobile applications for the operating room with a focus on improving patient safety, quality and outcomes, enabling hospitals to guide patient care and reduce costs.
Contact Information
Website
www.gausssurgical.comCorporate Office
- 4085 Campbell Avenue
- Suite 200
- Menlo Park, CA 94025
- United States
Corporate Office
- 4085 Campbell Avenue
- Suite 200
- Menlo Park, CA 94025
- United States
Gauss Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 07-Sep-2021 | $160M | Completed | Generating Revenue | ||
| 12. Later Stage VC (Series C) | 27-Oct-2020 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Private | 01-Jul-2020 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 12-Jun-2018 | Completed | Clinical Trials - General | |||
| 9. Later Stage VC (Series B) | 30-Mar-2016 | Completed | Clinical Trials - General | |||
| 8. Early Stage VC (Series A2) | 19-Aug-2015 | Completed | Clinical Trials - General | |||
| 7. Accelerator/Incubator | 09-Mar-2015 | Completed | Startup | |||
| 6. Early Stage VC (Series A1) | 30-Oct-2014 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | 06-Sep-2013 | $3.13M | $5.53M | Completed | Startup | |
| 4. Seed Round | 01-Feb-2013 | $1.4M | $2.4M | Completed | Startup |
Gauss Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 4,358,241 | $0.000100 | $0.02 | $0.46 | $0.46 | 1x | $0.46 | 4.28% |
| Series A | 17,292,700 | $0.000100 | $0.01 | $0.36 | $0.36 | 1x | $0.36 | 17% |
Gauss Comparisons
Industry
Financing
Details
Gauss Competitors (16)
One of Gauss’s 16 competitors is Retia Medical, a Venture Capital-Backed company based in White Plains, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Retia Medical | Venture Capital-Backed | White Plains, NY | ||||
| Masimo | Formerly PE-Backed | Irvine, CA | ||||
| ZOLL Medical | Corporate Backed or Acquired | Chelmsford, MA | ||||
| Majelco Medical | Corporation | Woods Cross, UT | ||||
| Omron Healthcare | Formerly VC-backed | Lake Forest, IL |
Gauss Patents
Gauss Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021202866-A1 | Image-based analysis of a test kit | Inactive | 02-Apr-2020 | ||
| WO-2021188994-A1 | Contactless healthcare screening | Inactive | 20-Mar-2020 | ||
| CA-3169587-A1 | Instrument tracking machine | Pending | 31-Jan-2020 | ||
| JP-2023513060-A | Instrument tracking machine | Active | 31-Jan-2020 | ||
| WO-2021154717-A1 | Instrument tracking machine | Inactive | 31-Jan-2020 | A61B90/36 |
Gauss Signals
Gauss Former Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Allumia Ventures Management | Venture Capital | Minority | ||
| Cannon (Italy) | Corporation | Minority | ||
| Corewell Health Ventures | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Gauss FAQs
-
When was Gauss founded?
Gauss was founded in 2011.
-
Where is Gauss headquartered?
Gauss is headquartered in Menlo Park, CA.
-
What is the size of Gauss?
Gauss has 52 total employees.
-
What industry is Gauss in?
Gauss’s primary industry is Monitoring Equipment.
-
Is Gauss a private or public company?
Gauss is a Private company.
-
What is the current valuation of Gauss?
The current valuation of Gauss is .
-
What is Gauss’s current revenue?
The current revenue for Gauss is .
-
How much funding has Gauss raised over time?
Gauss has raised $53.6M.
-
Who are Gauss’s investors?
Allumia Ventures Management, Cannon (Italy), Corewell Health Ventures, , and are 5 of 29 investors who have invested in Gauss.
-
Who are Gauss’s competitors?
Retia Medical, Masimo, ZOLL Medical, Majelco Medical, and Omron Healthcare are some of the 16 competitors of Gauss.
-
When was Gauss acquired?
Gauss was acquired on 07-Sep-2021.
-
Who acquired Gauss?
Gauss was acquired by Stryker.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process